Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis (vol 169, pg 1886, 2006)

被引：0
|
作者：
Luo, Yan
机构：
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2007年 / 171卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：1078 / 1078
页数：1
相关论文
共 50 条
  • [31] Tumor necrosis factor receptor 2 polymorphism in systemic lupus erythematosus: no association with disease. (vol 62, pg 1148, 2001)
    Lee, EB
    Yoo, JE
    Lee, YJ
    Choi, YJ
    Park, KS
    Song, YW
    HUMAN IMMUNOLOGY, 2002, 63 (03) : 235 - 235
  • [32] Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2-mediated signaling pathways in lung cancer
    Li, Fajiu
    Huang, Jie
    Ji, Dongyuan
    Meng, Qinghua
    Wang, Chuanhai
    Chen, Shi
    Wang, Xiaojiang
    Zhu, Zhiyang
    Jiang, Cheng
    Shi, Yi
    Liu, Shuang
    Li, Chenghong
    ONCOLOGY LETTERS, 2017, 14 (01) : 89 - 96
  • [33] Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1–TNFR2 cooperation
    A Wicovsky
    F Henkler
    S Salzmann
    P Scheurich
    C Kneitz
    H Wajant
    Oncogene, 2009, 28 : 1769 - 1781
  • [34] TUMOR NECROSIS FACTOR RECEPTOR-1 (TNFR1) SIGNALOSOME IS INFLUENCED BY JANUS KINASE 2 (JAK2)-MEDIATED RECEPTOR TYROSINE PHOSPHORYLATION
    Hapil, F. Z.
    Ertosun, M. G.
    Copuroglu, F. E.
    Ozes, O. N.
    CYTOKINE, 2016, 87 : 71 - 71
  • [35] Impaired angiogenesis after Hindlimb ischemia in type 2 diabetes Mellitus - Differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1
    Hazarika, Surovi
    Dokun, Ayotunde O.
    Li, Yongjun
    Popel, Aleksander S.
    Kontos, Christopher D.
    Annex, Brian H.
    CIRCULATION RESEARCH, 2007, 101 (09) : 948 - 956
  • [36] Resistance of rheumatoid arthritis synovial fibroblasts to p38 MAP-kinase inhibition of pro-destructive functions mediated by tumor necrosis factor alpha/tumor necrosis factor receptor-1
    Kunisch, E.
    Ukena, B.
    Fuhrmann, R.
    Roth, A.
    Winter, R.
    Kinne, R. W.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S43 - S43
  • [37] Resistance of rheumatoid arthritis synovial fibroblasts to p38 MAP-kinase inhibition of pro-destructive functions mediated by tumor necrosis factor alpha/tumor necrosis factor receptor-1
    E Kunisch
    B Ukena
    R Fuhrmann
    A Roth
    R Winter
    RW Kinne
    Arthritis Research & Therapy, 7
  • [38] Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells
    Turner, SJ
    La Gruta, NL
    Stambas, J
    Diaz, G
    Doherty, PC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (10) : 3545 - 3550
  • [39] Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins (vol 166, pg 407, 2004)
    Goel, HL
    Fornaro, M
    Moro, L
    Teider, N
    Rhim, JS
    King, M
    Lanquino, LR
    JOURNAL OF CELL BIOLOGY, 2004, 167 (03): : 565 - 565
  • [40] Erratum: Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1–TNFR2 cooperation
    A Wicovsky
    F Henkler
    S Salzmann
    P Scheurich
    C Kneitz
    H Wajant
    Oncogene, 2009, 28 : 3008 - 3008
12345